Leptin: Physiology and What Research Reports

What Is Leptin?

Leptin is a hormone produced predominantly by white adipose tissue that circulates in proportion to body fat mass and acts on receptors in the brain. Reviews tracing the hormone's history reported that leptin was identified as the product of the ob gene in 1994 and that its discovery reframed adipose tissue as an endocrine organ rather than inert storage (PMID 39245434). A later retrospective described three decades of work establishing leptin as a hormonal signal of energy availability and mapping its receptor and downstream signalling pathways (PMID 41043250).

Because leptin is a protein hormone, readers often encounter it in lists of "peptide hormones" alongside insulin, ghrelin and growth hormone. This page is for educational purposes only and is not medical advice; consult a licensed physician for any question about health, diagnosis or treatment.

Where Leptin Is Produced

The main source of circulating leptin is the adipocyte. Comprehensive physiology reviews described leptin as secreted mainly by adipose tissue in proportion to fat stores, with smaller contributions from other tissues, and reported that its secretion is regulated by nutritional state, insulin, glucocorticoids and inflammatory signals (PMID 29357132). Reviews of leptin and obesity likewise reported that leptin concentrations rise with increasing adiposity and fall with energy restriction and fat loss (PMID 34084149).

What Leptin Does in the Body

Energy balance

Work summarised in Nature Metabolism reported that leptin functions less as a moment-to-moment satiety signal and more as an endocrine signal of energy sufficiency, with falling leptin during energy deficit driving increased hunger and reduced energy expenditure (PMID 32694767). Physiology reviews reported that leptin acts on hypothalamic neuronal populations, including those expressing POMC and AgRP, through the long-form leptin receptor and JAK–STAT signalling (PMID 29357132).

Neuroendocrine and reproductive signalling

Reviews reported that low leptin, as occurs in starvation or leptin deficiency, was associated with suppression of reproductive, thyroid and growth axes, consistent with leptin acting as a permissive signal that sufficient energy is available (PMID 32694767). The history review also described leptin's broader signalling roles beyond appetite, including immune and neuroendocrine effects (PMID 39245434).

Developmental programming

A review of leptin and metabolic programming reported that leptin exposure during early life, including through milk and perinatal surges, influenced hypothalamic development and later metabolic phenotype in experimental models (PMID 35010989).

Peripheral tissues

Beyond the brain, a 2025 study reported that leptin acted as a key driver of organ fibrogenesis, linking the hormone to fibrotic remodelling in peripheral tissues (PMID 41124259). Reviews of leptin in obesity also reported associations between chronically elevated leptin and inflammatory and cardiometabolic processes (PMID 40932169).

How Leptin Is Measured and Studied

In clinical and translational research, leptin is typically quantified in serum or plasma by immunoassay and interpreted against fat mass, since concentrations track adiposity; reviews reported that this proportionality is the basis for describing obesity as a hyperleptinaemic state (PMID 34084149). Mechanistic work has relied heavily on genetic models: the history review reported that leptin-deficient (ob/ob) and receptor-deficient (db/db) rodents were central to identifying the hormone and its receptor (PMID 39245434). Human studies described in the same literature included rare monogenic leptin deficiency and lipodystrophy syndromes, in which leptin is absent or very low (PMID 30780830).

Leptin Resistance: What the Literature Describes

A 25-year retrospective reported that most people with obesity have elevated rather than deficient leptin, and that the failure of these high levels to restrain body weight has been described as leptin resistance (PMID 31717265). A dedicated review of the concept reported candidate mechanisms including impaired leptin transport across the blood–brain barrier, inflammation and endoplasmic reticulum stress, and negative-feedback inhibition of receptor signalling (PMID 30390289). A 2025 review of current evidence reported that leptin resistance remains incompletely defined mechanistically and outlined future research directions, including strategies aimed at restoring leptin sensitivity (PMID 40932169).

Leptin, Weight Change and Therapeutic Research

Researchers have examined whether leptin levels are a cause or a consequence of weight change. One study in Diabetes reported that a reduction in leptin was a required component for weight loss in the model examined, positioning falling leptin as part of the mechanism rather than merely a marker (PMID 37935033). On the therapeutic side, a review of leptin-based therapeutics reported that leptin replacement produced marked benefit in congenital leptin deficiency and in lipodystrophy, while responses in common obesity were limited, and that combination approaches and leptin sensitisers were therefore explored (PMID 30780830). Reviews of leptin and obesity reported similar clinical implications: leptin's utility appeared greatest in leptin-deficient states (PMID 34084149).

Why the Term Appears in Peptide Discussions

Leptin is a protein hormone, so it is frequently grouped with peptide hormones in educational material, and "leptin peptide" is often used loosely to mean either the native hormone, its fragments, or the recombinant analogue studied in deficiency syndromes. The cited literature discusses leptin as an endogenous hormone and as an investigational or replacement therapy in rare conditions; it does not describe general use in otherwise healthy people (PMID 30780830). Materials sold for laboratory work are labelled research use only and are not medicines.

Leptin in Research Settings: What Studies Report

Reported limitations and concerns in the cited literature centre on efficacy and biology rather than on any consumer protocol. Reviews reported that leptin administration largely failed to reduce body weight in people with common obesity because of pre-existing leptin resistance, which constrained its development as a weight-loss agent (PMID 30780830). Mechanistic reviews reported that chronically high leptin in obesity was associated with inflammatory and cardiometabolic changes rather than protection (PMID 40932169), and a 2025 report described leptin driving fibrogenesis across organs, which researchers framed as a potentially harmful downstream effect of elevated leptin signalling (PMID 41124259). None of the cited papers support conclusions about safety outside their stated study populations.

Key Takeaways From the Cited Literature

• Leptin is secreted mainly by adipocytes in proportion to fat mass (PMID 29357132).
• It was reported to act as an endocrine signal of energy sufficiency, with low levels driving compensatory hunger and reduced expenditure (PMID 32694767).
• Obesity was described as a high-leptin, low-responsiveness state (PMID 31717265).
• Replacement was reported to be most effective in leptin-deficient syndromes (PMID 30780830).

References

• Leptin and Obesity: Role and Clinical Implication (Frontiers in Endocrinology, 2021)
• Leptin Function and Regulation (Comprehensive Physiology, 2017)
• Leptin and the endocrine control of energy balance (Nature Metabolism, 2019)
• Leptin-based therapeutics (Expert Review of Endocrinology & Metabolism, 2010)
• History and future of leptin: Discovery, regulation and signaling (Metabolism, 2024)
• Leptin and Metabolic Programming (Nutrients, 2021)
• Leptin, Obesity, and Leptin Resistance: Where Are We 25 Years Later? (Nutrients, 2019)
• Leptin and leptin resistance in obesity: current evidence, mechanisms and future directions (Endocrine Connections, 2025)
• Leptin: 30 Years Later (Annual Review of Physiology, 2026)
• Leptin Reduction as a Required Component for Weight Loss (Diabetes, 2024)
• The Leptin Resistance (Advances in Experimental Medicine and Biology, 2018)
• Leptin as a key driver for organ fibrogenesis (Science Advances, 2025)